- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05903066
Definition af transmural heling ved CroHns sygdom (TRENCH 1) (TRENCH 1)
Definition af transmural heling i CroHns sygdom - TRENCH1-undersøgelsen
Multicenter prospective cross-sectional study of CD patients, its aim is the construction of an objective and reproducible system for evaluation of Transmural healing in Crohn's Disease (CD).
Primary objective : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Number of patients : 210 patients, in 14 sites (only one investigator per site), 15 patients per site, 5 patients per grade of transmural healing based on the appraisal of a local reader pair (a gastroenterologist and a radiologist).
Recruitment period : 2 years
Primary Endpoint : Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Secondary Endpoints :
- To analyze intra- and inter-observer variability of radiological findings.
- To analyze intra- and inter-observer variability of TH definitions in CD.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Liège, Belgien, 4000
- CHU de Liège
-
-
-
-
-
Amiens, Frankrig, 80054
- CHU Amiens-Picardie (site Sud)
-
Bordeaux, Frankrig, 33600
- CHU de Bordeaux - Hôpital Haut-Lévêque
-
Boulogne-Billancourt, Frankrig, 92100
- APHP - Hôpital Ambroise Paré
-
Clermont-Ferrand, Frankrig, 63003
- CHU de Clermont-Ferrand - Hôpital d'Estaing
-
Lille, Frankrig, 59037
- CHRU de Lille - Hôpital Claude Huriez
-
Limoges, Frankrig, 87000
- CHU Limoges Dupuytren
-
Marseille, Frankrig, 13015
- AP-HM - Hôpital Nord
-
Montpellier, Frankrig, 34295
- CHU de Montpellier - Hôpital Saint Eloi
-
Nantes, Frankrig, 44093
- CHU de Nantes
-
Nîmes, Frankrig, 30029
- CHU de Nîmes - Hôpital Carémeau
-
Pierre-Bénite, Frankrig, 69475
- Hospices Civils de Lyon
-
Rennes, Frankrig, 35033
- CHU Rennes - Hôpital Pontchaillou
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Patients diagnosed with CD for more than 6 months with histological confirmation available in his medical record, with an indication for MRE based on routine clinical practice validated by the treating physician
Beskrivelse
Inclusion Criteria:
- ≥ 18 years of age
- Patient diagnosed with CD for more than 6 months with histological confirmation available in his medical record.
- Indication for MRE based on routine clinical practice validated by the treating physician
- Any CD treatment will be authorized, such as biologicals (infliximab, adalimumab, vedolizumab, ustekinumab…), or immunomodulators (azathioprine, 6-mercaptopurine, methotrexate…).
- The subjects sign and date a written, informed consent form and any required privacy authorization prior to the initiation of the study.
- A subject can be enrolled into the study only if the grade of TH (assessed by the LRP) corresponding to the subject is not already fulfilled.
Exclusion Criteria:
- Pregnancy during the study
- People unable to give consent (because of their physical or mental state)
- Absence of written consent
- Ulcerative colitis or unclassified IBD
- Specific postsurgical settings: ileoanal anastomosis, ileostomy or colostomy.
- Less than 3 evaluable ileocolic segments or more than 3 resected ileocolonic segments (not counting ileocecal valve)
- Severe obstructive symptoms
- Symptomatic intra-abdominal abscess
- Contraindication for MRI
- Isolated perianal disease without luminal location
- MRE images of poor quality, based on previously defined criteria
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Objective definition of depth or grade of transmural healing in relation to radiologic signs observed during Magnetic Resonance Enterography (MRE) in CD
Tidsramme: Day 1
|
An index (depth of remission) or score (grade of remission) will be constructed through multiple linear or logistic mixed regression models. |
Day 1
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Intra- and inter-observer variability of lesions observed per segment during MRE in CD
Tidsramme: Day 1
|
Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items. |
Day 1
|
|
Intra- and inter-observer variability of depth and grade of global transmural healing in CD
Tidsramme: Day 1
|
Variations in MRE readings images between the CR will be quantified through the Kappa coefficient for qualitative items and through the intraclass correlation coefficient for quantitative items. |
Day 1
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Sophie GEYL, CHU Limoge Dupuytren
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- GETAID-2022-03
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .